Regulation Medicaid Reentry Waivers Are Opening a New Market in Addiction Care. The Weeks After Release Are the Deadliest for Overdose, and Coverage Now Reaches Through the Gate. Read More
Regulation GLP-1 Drugs for Addiction Are Moving From Anecdote to Evidence. A 2026 Trial Suggests Semaglutide Can Blunt the Urge to Drink. Read More
